In a landmark study that could redefine the clinical approach to metabolic bone diseases, a research team led by Professor…
Read More

In a landmark study that could redefine the clinical approach to metabolic bone diseases, a research team led by Professor…
Read More
Novartis has achieved significant regulatory successes on two fronts, with its oral therapy Rhapsido (remibrutinib) receiving marketing authorisation from the…
Read More
In a landmark study that promises to redefine the landscape of musculoskeletal medicine, researchers at the Institute of Science Tokyo…
Read More
The intricate balance of the human skeletal system relies on a continuous cycle of renewal known as bone remodeling, a…
Read More
Researchers at the Institute of Science Tokyo (Science Tokyo) have identified a critical protein, Family with Sequence Similarity 102 Member…
Read More
The landscape of regenerative medicine and orthopedics has been significantly altered by a landmark study identifying a singular protein, family…
Read More
The biological understanding of neurodegenerative diseases and oncological progression has been fundamentally shifted following a landmark study by investigators at…
Read More
The landscape of hematological oncology is facing a potential paradigm shift following a landmark study by Ludwig Cancer Research, which…
Read More
The landscape of regenerative medicine and orthopedics has been significantly advanced by the identification of Family with Sequence Similarity 102…
Read More